Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 172,262	$ 29	$ 318,574	$ 313	$ (146,654)
Beginning balance, shares at Dec. 31, 2020		29,543,222
Exercise of stock options	5,818	$ 1	5,817
Exercise of stock options, shares		324,041
Stock based compensation	21,360		21,360
Foreign currency translation adjustment	18			18
Other comprehensive loss	(260)			(260)
Net loss	(66,546)				(66,546)
Ending balance at Sep. 30, 2021	132,652	$ 30	345,751	71	(213,200)
Ending balance, shares at Sep. 30, 2021		29,867,263
Beginning balance at Jun. 30, 2021	142,080	$ 30	333,427	117	(191,494)
Beginning balance, shares at Jun. 30, 2021		29,655,786
Exercise of stock options	4,706		4,706
Exercise of stock options, shares		211,477
Stock based compensation	7,618		7,618
Foreign currency translation adjustment	18			18
Other comprehensive loss	(64)			(64)
Net loss	(21,706)				(21,706)
Ending balance at Sep. 30, 2021	132,652	$ 30	345,751	71	(213,200)
Ending balance, shares at Sep. 30, 2021		29,867,263
Beginning balance at Dec. 31, 2021	118,586	$ 30	355,234	(79)	(236,599)
Beginning balance, shares at Dec. 31, 2021		30,074,412
Issuance of common stock in connection with open market sales agreement, net of issuance costs	608		608
Issuance of common stock in connection with open market sales agreement, net of issuance costs, shares		51,769
Issuance of common stock on exercise of stock options and vesting of restricted stock units	148		148
Issuance of common stock on exercise of stock options and vesting of restricted stock units, shares		484,125
Stock based compensation	14,986		14,986
Value of share Issued in connection with acquisition of Novosteo	16,503	$ 6	16,497
Share issuance in connection with acquisition of Novosteo Inc.		5,520,000
Foreign currency translation adjustment	481			481
Other comprehensive loss	(655)			(655)
Net loss	(46,126)				(46,126)
Ending balance at Sep. 30, 2022	104,531	$ 36	387,473	(253)	(282,725)
Ending balance, shares at Sep. 30, 2022		36,130,306
Beginning balance at Jun. 30, 2022	111,532	$ 36	386,766	(466)	(274,804)
Beginning balance, shares at Jun. 30, 2022		35,977,688
Issuance of common stock on exercise of stock options and vesting of restricted stock units	13		13
Issuance of common stock on exercise of stock options and vesting of restricted stock units, shares		152,618
Stock based compensation	694		694
Foreign currency translation adjustment	343			343
Other comprehensive loss	(130)			(130)
Net loss	(7,921)				(7,921)
Ending balance at Sep. 30, 2022	$ 104,531	$ 36	$ 387,473	$ (253)	$ (282,725)
Ending balance, shares at Sep. 30, 2022		36,130,306